MY151457A - Topical formulation and uses thereof - Google Patents

Topical formulation and uses thereof

Info

Publication number
MY151457A
MY151457A MYPI20091998A MY151457A MY 151457 A MY151457 A MY 151457A MY PI20091998 A MYPI20091998 A MY PI20091998A MY 151457 A MY151457 A MY 151457A
Authority
MY
Malaysia
Prior art keywords
comfrey
analogue
derivative
topical formulation
provides
Prior art date
Application number
Other languages
English (en)
Inventor
Mckay Larry
Patel Kanu
Capon Robert John
Original Assignee
Arthritis Relief Plus Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arthritis Relief Plus Ltd filed Critical Arthritis Relief Plus Ltd
Publication of MY151457A publication Critical patent/MY151457A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
MYPI20091998 2006-11-15 2007-11-15 Topical formulation and uses thereof MY151457A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86600106P 2006-11-15 2006-11-15
US98107707P 2007-10-18 2007-10-18

Publications (1)

Publication Number Publication Date
MY151457A true MY151457A (en) 2014-05-30

Family

ID=39401247

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20091998 MY151457A (en) 2006-11-15 2007-11-15 Topical formulation and uses thereof

Country Status (11)

Country Link
US (2) US10322155B2 (OSRAM)
EP (2) EP2086561A4 (OSRAM)
JP (1) JP5694665B2 (OSRAM)
CN (1) CN101583369B (OSRAM)
AU (1) AU2007321711B2 (OSRAM)
CA (1) CA2669918C (OSRAM)
HK (1) HK1251167A1 (OSRAM)
MY (1) MY151457A (OSRAM)
NZ (1) NZ577604A (OSRAM)
RU (1) RU2467759C2 (OSRAM)
WO (1) WO2008058333A1 (OSRAM)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009012372A1 (en) * 2007-07-18 2009-01-22 Advantageous Systems, Llc Methods and apparatuses for detecting analytes in biological fluid of an animal
AU2010255336A1 (en) * 2009-06-05 2012-01-12 Sunev Pharma Solution Limited Topical micro-emulsions for the treatment of rheumatic disorders
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
CA3062005C (en) 2009-08-21 2022-02-15 Novan, Inc. Topical gels comprising nitric oxide-releasing polysiloxane macromolecules and uses thereof
RU2487882C1 (ru) 2009-10-29 2013-07-20 Майлан Груп Галлотанниновые соединения в композициях для покрытия литографических печатных форм
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2013006613A1 (en) * 2011-07-05 2013-01-10 Novan, Inc. Methods of manufacturing topical compositions and apparatus for same
WO2013162723A1 (en) * 2012-04-27 2013-10-31 Dow Corning Corporation Topical formulation compositions containing silicone based excipients to deliver actives to a substrate
DE202012013584U1 (de) * 2012-10-22 2018-01-15 Briu Gmbh Pharmazeutische Formulierung enthaltend Curcumin
WO2014085914A1 (en) * 2012-12-06 2014-06-12 Misudan Enterprises Inc. Topical liposome compositions containing phenolic anti-inflammatory agents and their methods of preparation
US20150005391A1 (en) 2013-06-26 2015-01-01 COLE Research & Design, Inc. Method of reducing scarring
CA2938388C (en) * 2014-02-10 2018-07-17 Troikaa Pharmaceuticals Limited Topical formulations of heparin
CN107205978B (zh) * 2014-12-24 2021-03-02 塞诺菲-安万特医疗保健私人有限公司 制剂及其制备方法和应用
CA2994331C (en) * 2015-07-31 2023-10-03 Delivra Inc. Transdermal formulations for delivery of capsaicinoids
US9867827B1 (en) * 2015-08-27 2018-01-16 Florida A&M University Methods and formulations for topical treatment of psoriasis
US10099995B2 (en) 2015-12-24 2018-10-16 Cole Research and Design, LLC Resveratrol esters
CN113413375A (zh) * 2016-05-30 2021-09-21 傅远桥 皮肤多种损伤创面治疗的外用药物组合物及其制备方法
WO2018164662A1 (en) 2017-03-06 2018-09-13 Elsohly Mahmoud A Resveratrol esters
CN108175765A (zh) * 2017-12-01 2018-06-19 东南大学 一种酸敏控释抗炎凝胶及其制备方法与应用
DE202017107326U1 (de) * 2017-12-01 2018-11-21 Kerstin Kräft Hautpflegeemulsion
GR1009658B (el) * 2018-06-18 2019-11-28 Δημητριος Ιωαννη Πουλακας Γελη για την ανακουφιση του πονου αρθρωσεων και ρευματικων παθησεων
CN110526746A (zh) * 2019-08-05 2019-12-03 深圳市芭田生态工程股份有限公司 一种聚氨酯包膜尿素的表面处理方法及聚氨酯包膜尿素
JP7163261B2 (ja) * 2019-09-27 2022-10-31 富士フイルム株式会社 水中油型乳化組成物、及び皮膚外用剤
GB202003666D0 (en) * 2020-03-13 2020-04-29 Epitheal Ltd Topical preparations
WO2021260712A1 (en) * 2020-06-26 2021-12-30 Rohan Sharadanand Phatak A liposomal composition of pterocarpus santalinus and the process thereof
US12109283B2 (en) * 2021-01-20 2024-10-08 Galaxy Surfactants Ltd. Safe and ecofriendly persistent sanitizing gel for topical application
US20240009262A1 (en) * 2022-07-09 2024-01-11 Uab Orbio World Cleansing pad and composition for reducing toxins
CN116392470B (zh) * 2022-10-11 2025-08-01 上海市皮肤病医院 紫草酸在制备治疗糖尿病溃疡药物中的应用
CN116036024B (zh) * 2022-11-15 2024-03-08 国科温州研究院(温州生物材料与工程研究所) 一种植物多酚微球及其制备方法和应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3903307A (en) * 1972-08-23 1975-09-02 Yosiaki Kimura Process of making the feed stuff containing bagasse, protein, and yeast
US4059695A (en) 1974-02-14 1977-11-22 Kanari Hirosaki Method for manufacturing a tonic composition for man and other animals
US4381296A (en) * 1980-06-23 1983-04-26 Tinnell James E Treatment for herpes virus
US4670263A (en) * 1983-12-29 1987-06-02 Noorlander Daniel O Nontoxic, germicide, and healing compositions
US5028429A (en) 1989-01-17 1991-07-02 Gochenouer Charles J Leg blister
US5213798A (en) * 1990-02-16 1993-05-25 Manikas John T Antiviral agent derived from the hull of the kukui nut
RO108532B1 (ro) * 1990-02-26 1994-06-30 Iulia Siminiciuc Produs medicamentos, cu acțiune antireumatismală
CZ277721B6 (en) * 1990-12-29 1993-03-17 Bohm Stanislav Massage ointment containing plant extracts and process for preparing such ointment
RU2044547C1 (ru) * 1993-11-18 1995-09-27 Леонид Петрович Бурага Средство для профилактики и лечения злокачественных новообразований
JP3319870B2 (ja) * 1994-04-13 2002-09-03 一丸ファルコス株式会社 皮膚外用組成物及び浴用剤
JPH08208451A (ja) 1995-02-03 1996-08-13 Kao Corp 植物生薬抽出物配合美白剤
JP3229917B2 (ja) * 1995-04-05 2001-11-19 三菱電機株式会社 望遠鏡ドームの換気制御装置
JPH09143079A (ja) * 1995-11-21 1997-06-03 Chiyuuyakuken:Kk 病変異常組織治療用外用剤
RO113711B1 (ro) 1996-02-22 1998-10-30 Dumitru Dobrescu Medicament pentru tratamentul afecţiunilor inflamatoare, erozive şi/sau atrofice, ale aparatului genital feminin
US5847003A (en) * 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
US5958418A (en) 1997-01-22 1999-09-28 Johnson Prillerman; Kathleen O. External herbal composition for treating muscle aches and joint pain
US5962018A (en) * 1998-04-28 1999-10-05 Avon Products, Inc. Method of treating the skin with organic acids in anhydrous microsphere delivery systems
JP2000236848A (ja) * 1998-12-02 2000-09-05 Kanebo Ltd β−ヘキソサミニダーゼ遊離抑制剤及びそれを含有する抗炎症用食品
JP3470182B2 (ja) * 1999-08-27 2003-11-25 リアル化学株式会社 新規な染毛剤およびそれを用いた染毛方法
JP2001064155A (ja) * 1999-08-30 2001-03-13 Shiga Yoko 新美白料素材
US6333056B1 (en) 2000-08-14 2001-12-25 Ralph Stanley Robinson Herbal-based pharmaceutical formulations
US6583184B1 (en) 2000-11-27 2003-06-24 Avon Products, Inc. Compositions having comfrey and methods for reducing retinoid-induced skin irritation
JP2002179547A (ja) * 2000-12-08 2002-06-26 Isehan:Kk 美白化粧料
JP4937458B2 (ja) 2001-03-05 2012-05-23 日本メナード化粧品株式会社 フキタンポポ抽出物含有光毒性抑制剤
US20040033246A1 (en) * 2002-06-25 2004-02-19 Kose Corporation Cosmetic for prevention of skin aging and agent for prevention of skin aging
CN1159326C (zh) * 2002-09-03 2004-07-28 四川省中医药研究院中医研究所 老鹳草块根鞣酸的提取方法
AU2003291015A1 (en) * 2002-11-15 2004-06-15 Wackvom Limited Compositions containing an active fraction isolated from tannins and methods of use
JP2004175734A (ja) * 2002-11-28 2004-06-24 Kose Corp 皮膚障害抑制剤、皮膚障害改善剤並びにそれらを含有する皮膚外用剤
US20040131704A1 (en) 2003-01-03 2004-07-08 Tammy Morse A method of organic and all natural treatment, prevention and relief of diaper dermatitis and other related skin irritations.
JP2004307456A (ja) * 2003-02-20 2004-11-04 Shiseido Co Ltd カスパーゼ−８活性阻害剤含有組成物
CA2521991A1 (en) * 2003-04-11 2004-10-28 Kyowa Hakko Kogyo Co., Ltd. Arthritis preventing or treating agent
EP1481683A1 (en) * 2003-05-30 2004-12-01 Yamanouchi Pharmaceutical Co. Ltd. P-selectin targeting ligand and compositions thereof
JP4770135B2 (ja) * 2004-07-26 2011-09-14 ゼリア新薬工業株式会社 外用剤
US7678768B2 (en) 2004-07-28 2010-03-16 Cargill Incorporated Physiologically-active composition based on collagen
ITMI20041882A1 (it) * 2004-10-05 2005-01-05 Francesco Setti Composizioni farmaceutiche topiche antinfiammatorie processo per la loro preparazione e loro usi
DE102005016486A1 (de) 2005-04-08 2006-10-12 Robert Bosch Gmbh Vorrichtung zum gelenkigen Verbinden eines Wischblatts mit einem Wischarm eines Scheibenwischers
WO2006113668A1 (en) 2005-04-15 2006-10-26 University Of South Florida A method of transdermal drug delivery using hyaluronic acid nanoparticles
DE102005021806A1 (de) * 2005-05-04 2006-11-16 Lancaster Group Gmbh Verwendung von radikalfangenden Substanzen zur Behandlung von Zuständen mit erhöhter Hauttemperatur, insbesondere zur antipyretischen Behandlung
GB2426703B (en) 2005-05-31 2007-09-19 Malvern Cosmeceutics Ltd Compositions
JP4891664B2 (ja) * 2006-06-20 2012-03-07 ヤンマー株式会社 コンバイン
RU113711U1 (ru) * 2011-07-22 2012-02-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Уфимский государственный авиационный технический университет" Спасательный жилет

Also Published As

Publication number Publication date
US10322155B2 (en) 2019-06-18
CA2669918A1 (en) 2008-05-22
EP2086561A4 (en) 2010-05-12
JP5694665B2 (ja) 2015-04-01
US11844820B2 (en) 2023-12-19
HK1251167A1 (en) 2019-01-25
AU2007321711A1 (en) 2008-05-22
AU2007321711B2 (en) 2013-01-17
CA2669918C (en) 2020-03-10
EP2086561A1 (en) 2009-08-12
CN101583369A (zh) 2009-11-18
WO2008058333A1 (en) 2008-05-22
RU2467759C2 (ru) 2012-11-27
JP2010509374A (ja) 2010-03-25
NZ577604A (en) 2012-06-29
CN101583369B (zh) 2015-03-11
US20190255133A1 (en) 2019-08-22
US20110038965A1 (en) 2011-02-17
RU2009122520A (ru) 2010-12-20
EP3284470A1 (en) 2018-02-21

Similar Documents

Publication Publication Date Title
WO2007075901A3 (en) Quinolin- 4 - one derivatives as modulators of abc transporters
WO2007011962A3 (en) Treatment of cancer
WO2005110994A8 (en) Substituted pyrazolyl urea derivatives useful in the treatment of cancer
UA95644C2 (ru) Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний
IL188475A0 (en) Pyrido [2,3-d]pyrimidine-2,4-diamine compounds as ptpib inhibitors
WO2007098352A3 (en) Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
WO2007092312A3 (en) Topical skin treating compositions
WO2007044084A3 (en) Heterocyclic inhibitors of mek and methods of use thereof
WO2006078287A3 (en) Pde4b inhibitors and uses therefor
TNSN08178A1 (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
WO2007051065A3 (en) Compositions and treatments for inhibiting kinase and/or hmg-coa reductase
DE602007006010D1 (de) Triazolopyrazinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
WO2007041130A3 (en) Deazapurines useful as inhibitors of janus kinases
MX2009008411A (es) Ectoparasiticida de accion prolongada con alta dosis para un control prolongado.
WO2008030883A3 (en) Treatment of cancer
WO2007035545A3 (en) Apparatus, method and system for building software by composition
WO2007098591A3 (en) Topical nail formulation
WO2008013987A3 (en) N-alkyl substituted piperazinylmethylquinazolinones and azepanylmethylquinazolinones
WO2008099874A1 (ja) ピラジン誘導体を含有する医薬組成物およびピラジン誘導体を組み合わせて使用する方法
WO2008079270A3 (en) Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
WO2011059324A3 (en) Composition for topical application, uses thereof, applicator device and kit of parts
WO2008034796A3 (en) Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors
TNSN07435A1 (en) Novel piperidine carboxylic acid amide derivatives
WO2006003492A3 (en) Compositions and methods for treating pathological infections
EP3939599A3 (en) Silicate containing compositions and methods of treatment